Gemtuzumab and ascites Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5087233-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Aug 08, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, cholestasis, coagulation factor v level increased, cytolytic hepatitis, loss of consciousness, multi-organ failure, prothrombin time prolonged, thrombocytopenia, venoocclusive liver disease. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, AZACTAM, AMIKIN, OMEPRAZOLE, FLUCONAZOLE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5087261-3
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Aug 08, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, ascites, cholestasis, cytolytic hepatitis, loss of consciousness, multi-organ failure, thrombocytopenia, venoocclusive liver disease, weight increased. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, AZACTAM, AMIKIN, OMEPRAZOLE, FLUCONAZOLE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4688359-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 01, 2005. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bronchopulmonary aspergillosis, fluid retention, hepatic congestion, hepatic steatosis, hepatomegaly, hepatotoxicity, hyperbilirubinaemia, lung disorder. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4911217-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from AUSTRIA on Jan 22, 2004. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, dyspnoea, gamma-glutamyltransferase increased, hepatic steatosis, hypokalaemia, liver function test abnormal. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, LISINOPRIL, TERAZOSIN, FLUCONAZOLE, VANCOMYCIN, MEROPENEM, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4603388-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Feb 28, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, cholestasis, cytolytic hepatitis, hepatomegaly, hepatotoxicity, multi-organ failure, oliguria, renal failure acute, sepsis . Gemtuzumab dosage: 4.8 MG 1X PER 1 CYC. During the same period patient was treated with CYTARABINE, ETOPOSIDE, IDARUBICIN, AMIKLIN, FORTUM, VANCOMYCIN. Patient died.

Gemtuzumab Side Effects Report #6039217-1
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 13, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hyperbilirubinaemia, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis, oedema, pneumonia . Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6042039-9
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 13, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hyperbilirubinaemia, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis, oedema, pneumonia . Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6057696-0
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 27, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hepatotoxicity, hyperbilirubinaemia, hypotension, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Gemtuzumab Side Effects Report #4867127-1
Gemtuzumab side effect was reported by a Physician from SPAIN on Mar 10, 2002. Male patient, 20 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anuria, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, hypocalcaemia, liver disorder. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DOS INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died.


Gemtuzumab Side Effects Report #4631147-2
Gemtuzumab side effect was reported by a Pharmacist from on Apr 07, 2005. Male patient, child 10 years of age, weighting 143.3 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, fluid overload, hyperbilirubinaemia, hypotension, sepsis , transaminases increased, venoocclusive liver disease. Gemtuzumab dosage: 7.8 MG X 1 DOSE INTRAVENOU. During the same period patient was treated with ALEMTUZUMAB, MEROPENEM, VANCOMYCIN, METHYLPREDNISOLONE, PENTAMIDINE, AMBISOME, PROZAC. Patient recovered.

Gemtuzumab Side Effects Report #5089444-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on Aug 10, 2006. Female patient, 62 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, atrial fibrillation , blood bilirubin increased, candidiasis, fluid retention, hepatic function abnormal. Gemtuzumab dosage: 5.2 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, IDARUBICIN, SULFAMETHOXAZOLE, COLISTIN. Patient died.